OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
Using a minimum valuable product and process approach would make it is possible to discipline and structure the development of biopharmaceuticals in the fastest way possible.
Assessment of peripheral blood protein glycosylation has recently become scalable, providing a new domain for biomarker research.
A strong digital backbone is foundational in driving innovation.
January 26, 2023
Agilent will work with Quest Diagnostics to distribute the ctDx FIRST test.
January 18, 2023
The BioProfile FAST CDV is a fully automated viable cell density and viability analyzer.
Pfizer and Gero have partnered to discover potential therapeutic targets for fibrotic diseases using machine learning technology.
The collaboration between AbbVie and Anima Biotech will combine Anima's mRNA Lightning technology platform with AbbVie's extensive expertise in oncology and immunology.
January 11, 2023
Advanced LC technologies can streamline the review process for LC equipment maintenance.
January 01, 2023
Biologic drug development requires relevant bioassays to measure and help predict cellular response.
December 22, 2022
Airing 1: Thursday January 19, 2023 at 11am EST | 4pm GMT| 5pm CET
Airing 2: Thursday January 19, 2023 at 2pm EST | 1pm CST| 11am PST
December 19, 2022
The launch of Discovery Life Sciences’ new Proteomic Services Division offers a single source for large-scale population studies, biobank characterization, and multi-omic biomarker analysis.
December 12, 2022
Generate Biomedicines published a preprint describing technology that can generate novel proteins towards desired functional or other properties.
PictorLabs, a digital pathology company developing an AI-powered virtual staining platform, formally announced its launch at the start of December.